Optimal Medical Therapy Estimated by FDG PET/CT in Myocardial Sarcoidosis
Not Applicable
- Conditions
- Myocardial sarcoidosis
- Registration Number
- JPRN-UMIN000022996
- Lead Sponsor
- The Department of Cardiology, Nagoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The patients with myelosuppression, chronic liver dysfunction, chronic kidney disease and infection.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of uptaking area estimated by 18F-FDG PET/CT
- Secondary Outcome Measures
Name Time Method Frequency of sudden cardiac death, lethal arrhythmia and heart failure.